X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
oncology (29) 29
male (24) 24
adult (23) 23
female (22) 22
middle aged (19) 19
chemotherapy (18) 18
aged (16) 16
index medicus (16) 16
prognosis (12) 12
sarcoma (12) 12
soft tissue sarcoma (11) 11
cancer (10) 10
imatinib mesylate (10) 10
care and treatment (9) 9
adolescent (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
prognostic-factors (8) 8
surgery (8) 8
survival (8) 8
benzamides (7) 7
combined modality therapy (7) 7
efficacy (7) 7
settore med/06 - oncologia medica (7) 7
treatment outcome (7) 7
tumors (7) 7
adults (6) 6
diagnosis (6) 6
ifosfamide (6) 6
piperazines - therapeutic use (6) 6
pyrimidines - therapeutic use (6) 6
retrospective studies (6) 6
soft-tissue sarcoma (6) 6
survival rate (6) 6
young adult (6) 6
aged, 80 and over (5) 5
antineoplastic agents - therapeutic use (5) 5
disease-free survival (5) 5
gastrointestinal stromal tumors (5) 5
immunohistochemistry (5) 5
sarcoma - diagnosis (5) 5
sarcoma - therapy (5) 5
survival analysis (5) 5
adjuvant chemotherapy (4) 4
analysis (4) 4
child (4) 4
child, preschool (4) 4
disease progression (4) 4
dosage and administration (4) 4
extremity (4) 4
gastrointestinal stromal tumors - drug therapy (4) 4
gastrointestinal stromal tumors - pathology (4) 4
gist (4) 4
hematology, oncology and palliative medicine (4) 4
medicine & public health (4) 4
mesylate (4) 4
patients (4) 4
research (4) 4
rhabdomyosarcoma (4) 4
safety (4) 4
sarcoma - mortality (4) 4
sarcoma - pathology (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
childhood tumors in adults (3) 3
children (3) 3
cisplatin - administration & dosage (3) 3
doxorubicin (3) 3
doxorubicin - administration & dosage (3) 3
drug dosages (3) 3
drug therapy (3) 3
gastrointestinal stromal tumors - genetics (3) 3
gastrointestinal stromal tumors - therapy (3) 3
immunophenotyping (3) 3
italy - epidemiology (3) 3
limbs (3) 3
liposarcoma (3) 3
management (3) 3
medical prognosis (3) 3
mesothelioma (3) 3
mesothelioma - drug therapy (3) 3
mesothelioma - surgery (3) 3
metastasis (3) 3
mutation (3) 3
neoadjuvant chemotherapy (3) 3
pathology (3) 3
patient outcomes (3) 3
pharmacology & pharmacy (3) 3
proto-oncogene proteins c-kit - genetics (3) 3
re-excision (3) 3
soft tissue neoplasms - mortality (3) 3
soft tissue neoplasms - pathology (3) 3
soft tissue neoplasms - therapy (3) 3
solid tumors (3) 3
surgical oncology (3) 3
therapy (3) 3
trial (3) 3
usage (3) 3
adolescence (2) 2
aggressive fibromatosis (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 98 - 107
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2009, Volume 15, Issue 18, pp. 5910 - 5916
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 364, Issue 9440, pp. 1127 - 1134
Journal Article
Medical Oncology, ISSN 1357-0560, 7/2019, Volume 36, Issue 7, pp. 1 - 8
Rhabdomyosarcoma (RMS) is rare in adults and it is generally characterized by poor outcome. In a previous retrospective study, we demonstrated a better... 
Multimodal treatment | Pathology | Childhood tumors in adults | Medicine & Public Health | Hematology | Treatment score | Rhabdomyosarcoma | Soft tissue sarcoma | Oncology | Internal Medicine | Adults | SURVIVAL | ONCOLOGY | CHEMOTHERAPY
Journal Article
Journal Article
CLINICAL SARCOMA RESEARCH, ISSN 2045-3329, 12/2017, Volume 7, Issue 1, pp. 20 - 6
Background: Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain lineage and intermediate biological potential. It is more common in... 
VARIANTS | Ifosfamide | PARTS | DOXORUBICIN | Soft tissue sarcoma | FOLLOW-UP | Isolated limb perfusion | Ossifying fibromyxoid tumor | Chemotherapy | GENE | ONCOLOGY | Epirubicin | FUSIONS | SOFT-TISSUE SARCOMA
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 01/2020, Volume 31, Issue 1, pp. 80 - 84
Tenosynovial giant cell tumour (TGCT) is a group of rare soft tissues neoplasia affecting synovial joints, bursae and tendon sheaths and is classified as... 
ONCOLOGY | DOXORUBICIN | KINASE | malignant tenosynovial giant cell tumour | pigmented villonodular synovitis | tenosynovial giant cell tumour | imatinib | PHARMACOLOGY & PHARMACY | pazopanib | chemotherapy | SOFT-TISSUE SARCOMA | Case Reports
Journal Article